'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitors.
Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Gibbs A, Kahl J, Kessler L, Lundström J, Miller S, Nakanishi H, Roberts E, Saiah E, Sullivan R, Wang Z, Larson CJ.
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5456-9. Epub 2008 Sep 11.PMID: 18835164 [PubMed - indexed for MEDLINE]Related articles